Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Price:
0.25 USD
66.67%
Updated:
May 17, 2024
Sonoma Pharmaceuticals Inc
Accrued Liabilities
|
Sonoma Pharmaceuticals Inc
Accrued Liabilities Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
Accrued Liabilities
$2m
|
CAGR 3-Years
18%
|
CAGR 5-Years
6%
|
CAGR 10-Years
13%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Accrued Liabilities
$28.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Accrued Liabilities
$9.9B
|
CAGR 3-Years
5%
|
CAGR 5-Years
15%
|
CAGR 10-Years
13%
|
|
|
Pfizer Inc
NYSE:PFE
|
Accrued Liabilities
$2.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
6%
|
CAGR 10-Years
5%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Accrued Liabilities
$13.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
4%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Accrued Liabilities
$10.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
16%
|
CAGR 10-Years
16%
|
See Also
What is Sonoma Pharmaceuticals Inc's Accrued Liabilities?
Accrued Liabilities
2m
USD
2m
USD
Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Accrued Liabilities amounts to 2m USD.
What is Sonoma Pharmaceuticals Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
13%
13%
Over the last year, the Accrued Liabilities growth was -18%. The average annual Accrued Liabilities growth rates for Sonoma Pharmaceuticals Inc have been 18% over the past three years , 6% over the past five years , and 13% over the past ten years .
You don't have any saved screeners yet
